Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.

Stephen R D Johnston; Tamas Hickish; Paul Ellis; Stephen Houston; Lloyd Kelland; Mitch Dowsett; Janine Salter; Bart Michiels; Juan Jose Perez-Ruixo; Peter Palmer

doi:10.1200/JCO.2003.10.064

Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.

Identifier:nobleid.org/w1/20260515/CF3ECC37

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF3ECC37.svg?ark=w1%2F20260515%2FCF3ECC37)](https://nobleid.org/work/w1/20260515/CF3ECC37)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Juan Jose Perez-Ruixo

Peter Palmer

Claim authorship of this work

Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.

Identifier:nobleid.org/w1/20260515/CF3ECC37

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CF3ECC37.svg?ark=w1%2F20260515%2FCF3ECC37)](https://nobleid.org/work/w1/20260515/CF3ECC37)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Juan Jose Perez-Ruixo

Peter Palmer

Claim authorship of this work